Search research articles
Contact Us
Filters
Showing results (91-100 of 103) with videos related to
Page
of 11
Sort By:
Blood Reviews
|
September 13, 2023
Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS)
Maximilian Stahl, Jan Philipp Bewersdorf, Zhuoer Xie, et al.
Blood
|
March 27, 2025
Reducing clinical trial eligibility barriers for patients with MDS: an icMDS position statement
Uma Borate, Kelly Pugh, Allyson Waller, et al.
Blood Advances
|
October 19, 2022
An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS
Maximilian Stahl, Omar Abdel-Wahab, Andrew H Wei, et al.
Blood
|
July 3, 2024
Molecular taxonomy of myelodysplastic syndromes and its clinical implications
Elsa Bernard, Robert P Hasserjian, Peter L Greenberg, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
September 25, 2024
Contemporary Approach to the Diagnosis and Classification of Myelodysplastic Neoplasms/Syndromes-Recommendations From the International Consortium for Myelodysplastic Neoplasms/Syndromes (MDS [icMDS])
Fnu Aakash, Savanah D Gisriel, Amer M Zeidan, et al.
Blood
|
April 30, 2024
Molecular and clinical presentation of UBA1-mutated myelodysplastic syndromes
Maria Sirenko, Elsa Bernard, Maria Creignou, et al.
Leukemia
|
June 22, 2022
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
Joseph D Khoury, Eric Solary, Oussama Abla, et al.
NEJM Evidence
|
February 6, 2024
Molecular International Prognostic Scoring System for Myelodysplastic Syndromes
Elsa Bernard, Heinz Tuechler, Peter L Greenberg, et al.
Nature Medicine
|
May 5, 2021
Author Correction: Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
Elsa Bernard, Yasuhito Nannya, Robert P Hasserjian, et al.
Nature Medicine
|
August 5, 2020
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
Elsa Bernard, Yasuhito Nannya, Robert P Hasserjian, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 103) with videos related to
Sort By:
Page
of 11
Blood Reviews
|
September 13, 2023
Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS)
Maximilian Stahl, Jan Philipp Bewersdorf, Zhuoer Xie, et al.
Blood
|
March 27, 2025
Reducing clinical trial eligibility barriers for patients with MDS: an icMDS position statement
Uma Borate, Kelly Pugh, Allyson Waller, et al.
Blood Advances
|
October 19, 2022
An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS
Maximilian Stahl, Omar Abdel-Wahab, Andrew H Wei, et al.
Blood
|
July 3, 2024
Molecular taxonomy of myelodysplastic syndromes and its clinical implications
Elsa Bernard, Robert P Hasserjian, Peter L Greenberg, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
September 25, 2024
Contemporary Approach to the Diagnosis and Classification of Myelodysplastic Neoplasms/Syndromes-Recommendations From the International Consortium for Myelodysplastic Neoplasms/Syndromes (MDS [icMDS])
Fnu Aakash, Savanah D Gisriel, Amer M Zeidan, et al.
Blood
|
April 30, 2024
Molecular and clinical presentation of UBA1-mutated myelodysplastic syndromes
Maria Sirenko, Elsa Bernard, Maria Creignou, et al.
Leukemia
|
June 22, 2022
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
Joseph D Khoury, Eric Solary, Oussama Abla, et al.
NEJM Evidence
|
February 6, 2024
Molecular International Prognostic Scoring System for Myelodysplastic Syndromes
Elsa Bernard, Heinz Tuechler, Peter L Greenberg, et al.
Nature Medicine
|
May 5, 2021
Author Correction: Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
Elsa Bernard, Yasuhito Nannya, Robert P Hasserjian, et al.
Nature Medicine
|
August 5, 2020
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
Elsa Bernard, Yasuhito Nannya, Robert P Hasserjian, et al.
Page
of 11